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ABSTRACT 
The aim of the present investigation was to formulate and evaluate topical calcineurin inhibitor loaded transfersomal drug delivery for vitiligo 
using rota evaporator followed by thin film method. Tacrolimus can restore the melanocytes if given in transfersomal gel. Fourier transform 
infrared spectroscopy (FTIR) had employed to study drug-excipients incompatibility. Analytical method was performed using UV 
spectrophotometer. Topical calcineurin inhibitor loaded transfersomal gel was evaluated for particle size, zeta potential, percent drug 
entrapment, surface morphology, in-vitro drug release study, in vitro permeability study and stability study. Optimization of process parameter 
was done by 32
 
full factorial Design Expert software. Topical calcineurin inhibitor was successfully prepared with drug:lipid(1:10), 
lipid:surfactant(9:1), water as hydration medium, chloroform:methanol(9:1) as solvent, HPMCK100 as mucoadhesive agent and extract of 
catechu powder to provide colour on skin. Optimization study of process parameter shows that batch prepared with hydration time 55 
min,evaporation time 15 min, hydration temperature is 50°C and temperature to form thin film is 60°C as optimum condition for rota evaporator. 
Particle size, zeta potential, percent drug entrapment were found to be 155.5 nm, -49 mV, 80% respectively for optimized batch. 
Keywords: Vitiligo, Tacrolimus, Transfersomal gel, Thin film hydration method, Vesicle size, PDE, Zeta-potential, Skin irritation study, Skin 
sustain study, Stability study. 
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INTRODUCTION  
Vitiligo is an autoimmune disorder observing with 
progressive loss of skin pigmentation.  Vitiligo is a cutaneous 
disease in which the melanocytes are damaged in discrete 
patches, resulting in lightened areas of variable size and 
location distributed throughout the skin of the body. 
Melanocytes are cells located in the stratum basale (bottom 
layer) of the skin's epidermis. The lightened lesions of the 
skin are immune-compromised and generally have greater 
susceptibility to the injurious effects of the sun, premature 
aging and possible cancer of the skin. The disease strikes 
about 1% of the world population, generally during 
adolescent years. The progressive loss of melanocytes from 
depigmenting vitiligo skin is accompanied by cellular 
infiltrates containing T lymphocytes. Infiltrating cytotoxic T 
cells with elevated similarity T cell receptors have likely 
escaped clonal removal in the thymus, allowing such T cells 
to enter the flow It is thought that through the appearance of 
cutaneous lymphocyte antigen, these T cells home to the 
skin where they express type 1cytokine profiles and 
mediate melanocyte apoptosis via the perforin pathway. As 
this state affects the skin and is readily visible to the public 
eye, there are many psychological and social trouble that can 
result1,2. 
Tacrolimus is first new topical drug for the treatment of 
moderate to severe vitiligo since the advent of topical 
corticosteroids. The mechanism of action of tacrolimus in 
vitiligo is not known. It has been demonstrated that 
tacrolimus inhibit T-limphocytes activation by first binding 
to an intracellular protein, FKBP-12. Tacrolimus is found to 
be effective in skin treating vitiligo with main side effect 
burning and irritant on skin. 
Transfersomes are ultra-deformable vesicles, elastic in 
nature, which can squeeze itself through a pore which is 
many times smaller than its size due to its elasticity. 
Transfersome have been reported to enhance the 
transdermal delivery of drugs, when applied onto the skin 
non- occlusively biocompatible, biodegradable, posses high 
entrapment efficiency, act as depot so releasing their 
contents slowly and gradually, ability to deform and pass 
through narrow constriction, can be used for systemic as 
well as topical drug delivery. Apart from their benefits, 
transfersomes are associated with some drawbacks such as: 
chemical instability, expensive to formulate and purity of 
natural phospholipids. 
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MATERIALS AND METHODS 
Tacrolimus was obtained as a gift sample from bills biotech. 
vadodara, phospholipids Soya phosphatidyl choline obtain 
from chemdyes corporation, vadodara, surfactant sodium 
cholate obtain from chemdyes corporation, vadodara, Muco-
adhesive HPMCK100M obtained from chemdyes corporation, 
vadodara. 
METHOD3, 4, 5 
Method of Preparation Transfersomes: 
Thin film hydration (TFH) method: The general elements of 
procedure involve preparation of lipid for hydration, 
hydration of lipid film, sizing of lipid suspension. 
1. Preparation of Lipid for Hydration: 
In this method, lipid mixture are dissolve in mixture of 
organic solvent in rotary evaporator flask and dry thin film 
of lipid is prepare using rotary evaporator. 
2. Hydration of Lipid Film: 
Flask is flushed with nitrogen and hydration of lipid is done 
by adding 10 ml of distilled water to be encapsulated and 
again use of rotary evaporator for making homogeneous 
milky white suspension. It is allowed to stand for 50 min at 
RT/above Tg (glass transition temperature) for complete 
swelling process. This process will finally produce the multi 
lamellar vesicles. Method of preparation of transferosomes 
by thin film method show in figure 1. 
 
 
Figure 1: Method of Preparation of Transfersomes by thin film method 
 
3. Sizing of Lipid Suspension: 
Disruption of MLV suspension using sonic energy (probe 
sonication) typically produces small, unilamellar vesicle with 
diameter in the range of 15-50 nm. The most common 
instrumentation for preparation of sonicated particle is bath 
and probe tip sonicators. Probe tip sornicator deliver high 
energy input to the lipid suspension for these reasons, probe 
tip sonicator are the widely used instrumentation for 
preparation of SUV. 
Transfersomal gel: 
Transfersomal gel formulation to be prepared by 
incorporation of transfersomal into a structure vehicle such 
as HPMCK100 or carbopol polymer. Even though 
transfersomes offers several advantages for topical delivery, 
it is difficult to stabilize the system because of low viscosity. 
This problem can be overcome by formulating transfersomal 
based hydrogel using polymer such as various grade of 
hydroxypropyl methylcellulose (HPMC). 
Thin film hydration method:
6
 
Thin film hydration technique was basically used in 
preparation of Transfersomes. A thin film was prepared 
from the mixture of vesicles forming ingredients that is 
phospholipids and surfactant by dissolving in volatile 
organic solvent Chloroform: Methanol (8:2) which was 
transferred to RBF for 15 min at 80 rpm under 350mm Hg 
and at 65°C .The film was hydrated using 20 ml distilled 
water for period of 55 min at 50°C and 65°C temperature. 
The resultant transfersomal dispersion was sonicated for 3 
min. Resultant transfersomal dispersion centrifuge at 3000 
rpm for 15 min to remove free drug. Prepared transfersomes 
were evaluated for percentage drug entrapment, vesicle size 
and zeta potential measurement. Preliminary trial batches 
were prepared using different surfactant such as sodium 
cholate, tween 80 and span 60.Trial batches for preparation 
of transfersomes are shown in table 1. Result of preliminary 
trial batches for selection of drug: lipid and lipid: surfactant 
molar ratio are shown in table 2 
 
Table 1: Preliminary trial batches for selection of drug:lipid and lipid:surfactant molar ratio 
S.N. Batch no Drug: lipid molar ratio  Lipid: Surfactant molar  ratio SPC(mg) Surfactant (mg) 
1 Sodium choline 1:10 7:3 67.47 15.50 
2 Sodium choline 1:20 9:1 41.85 2.58 
3 Sodium choline 1:10 9:1 83.70 5.16 
1 TWEEN-80 1:10 7:3 67.47 21.77 
2 TWEEN-80 1:20 9:1 83.70 7.25 
3 TWEEN-80 1:10 9:1 83.70 7.25 
1 SPAN-60 1:10 7:3 65.10 15.42 
2 SPAN-60 1:20 9:1 83.70 5.14 
3 SPAN-60 1:10 9:1 83.70 5.14 
Patel et al                                                                                                                     Journal of Drug Delivery & Therapeutics. 2019; 9(2-s):88-91 
ISSN: 2250-1177                                                                                  [90]                                                                                 CODEN (USA): JDDTAO 
Table 2: Preliminary trial batches for selection of surfactants 
Sr no Batch no Drug: lipid molar ratio Lipid: Surfactant molar ratio PDE Vesicle size (nm) 
1 SC 1:10 7:3 71.15 358 
2 SC 1:20 9:1 78.55 320 
3 SC 1:10 9:1 82.45 270 
4 TWEEN-80 1:10 7:3 35 882 
5 TWEEN-80 1:20 9:1 31 375 
6 TWEEN-80 1:10 9:1 78.42 364 
7 SPAN-60 1:10 7:3 38 347.5 
8 SPAN-60 1:20 9:1 44 216 
9 SPAN-60 1:10 9:1 68.26 187 
(SC-Sodium cholate) 
RESULT & DISCUSSION 
The objective of the present study was to formulate and 
evaluate calcineurin inhibitor loaded transfersomal drug 
delivery for vitiligo by thin film hydration method. 
Solubility Study: 
Based on solubility study in different solvent, it was found 
that methanol and chloroform maximum solubility for 
drug.show in table 3 
Viscosity: 
Measurement viscosity of gel is important because higher 
viscosity show difficulty on spreading while lower viscosity 
shows difficulty in retention of gel on skin. So optimum 
viscosity of gel was required for higher bioadhesion of gel on 
skin. The viscosity of transfersomal gel was found to be 
54±0.0149 Pas. The results are shown in table 4 
Spreadibility: 
The potential usefulness as a topical dosage form with 
desired semisolid consistency was demonstrated by 
spreadibility values indicating the ease of application on the 
skin. 
The spreadibility of transfersomal gel was found to be 
4.69±0.521(g cm/sec) which shown in table 4 
pH: 
The pH of the developed formulation was in accordance with 
that of human skin pH rendering them acceptable. The 
develop formulation had pH near to that of skin. 
Drug content uniformity: 
Drug content for transfersomal gel and marketed tacrolimus 
cream was found to be 82.6±0.75 & 72.4±0.59 respectively 
shown in table 5 
In-Vitro Drug Diffusion Study: 
Results obtained from in vitro diffusion studies evaluated 
with transfersomal gel and marketed ointment. The amount 
of Tacrolimus released in 24 hrs was found to be 82.25% and 
72.34% from Marketed tacrolimus ointment and tacrolimus 
transfersomal gel respectively shown in table 6  
Drug release: 
The correlation coefficient (r2) of the higuchi model were 
found to be near to 1(0.972 & 0.968 for transfersomal gel 
and marketed gel respectively)compare to the first order, 
Hixson-crowell’s cube root model, higuchi model. Hence the 
release of drug from the preparation followed 
predominantly zero order model shown in table 7 
Ex-Vivo Permeation Study: 
Result obtained from Ex-vivo drug permeation studies were 
shown in table 8. Significant augmentation in the permeation 
of tacrolimus has been observed with transfersomal gel 
formulation. 
Skin irritation study: 
Skin irritation study was carried out by using transfersomal 
gel and marketed ointment which are shown in figure 2 
 
Table 3: Stability data of tacrolimus containg transfersomal gel 
Sr no Parameter Storage periods(Days) at 25°C±2°C Temperature and 65±5% Relative Humidity 
  Before Storage After 15 days After 30 days 
1 Viscosity 54±0.0149 53±0.0524 52.5±0.0296 
2 pH 5.2 5.2 5.1 
3 %CDR 84.72±0.04 84.02±0.09 83.96±0.01 
 
Table 4: Spreadibility and Viscosity 
Parameter Result 
Viscosity 54±0.0149(Pa s) 
Spreadibility 4.69±0.527(g cm/sec) 
 
Table 5: Drug content uniformity of formulation 
Formulation Drug content 
Tacrolimus Transfersomal gel 82.6±0.75 
Tacrolimus ointment 72.4±0.59 
 
 
Table 6: In vitro drug diffusion study of tacrolimus from 
transfersomal gel and marketed ointment 
Time 
(hr) 
Mean cumulative percentage drug release ±SD 
Transfersomal gel Marketed ointment 
0.5 7.79±0.01 6.3±0.06 
1 16.88±0.03 9.8±0.14 
2 25.14±0.07 12.4±0.1 
4 36.19±0.16 16.56±0.15 
6 43.5±0.1 24.73±0.07 
8 51.46±0.05 25.26±0.06 
10 65.70±0.05 25.76±0.07 
12 72.54±0.05 - 
24 84.72±0.04 - 
Patel et al                                                                                                                     Journal of Drug Delivery & Therapeutics. 2019; 9(2-s):88-91 
ISSN: 2250-1177                                                                                  [91]                                                                                 CODEN (USA): JDDTAO 
Kinetic modeling and mechanism of drug release 
Table 7: Result of kinetic model fitted on transfersomal gel 
 
Diffusion model 
R2 Value 
Transfersomal gel 
(batch-7) 
Marketed ointment 
Zero-order plot 0.972 0.968 
First –order plot 0.685 0.682 
Higuchi plot 0.952 0.949 
Hixon plot 0.798 0.789 
Peppas plot 0.874 0.868 
 
Table 8: Ex vivo permeability study of tacrolimus from 
transfersomal gel and marketed ointment 
Time (hr) Transfersomal gel Marketed ointment 
0.5 6.48±0.3 5.33±0.09 
1 14.67±0.1 9.75±0.4 
2 23.43±0.2 11.53±0.1 
4 34.75±0.05 15.49±0.05 
6 39.57±0.16 23.75±0.14 
8 46.68±0.15 24.15±0.1 
10 55.54±0.15 - 
12 63.42±0.20 - 
24 65.95±0.36 - 
%Drug permeated per unit time ± S.D
 
 
 
A) Before B) After 24 hrs 
Figure 2: Rat skin irritation study using transfersomal gel containing tacrolimus 
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CONCLUSION 
Aim of research study was to prepare and evaluate topical 
calcineurin inhibitor loaded transfersomal drug delivery for 
vitiligo. Category of tacrolimus is an immunosuppressant 
and mainly used in vitiligo and acne. Skin irritation and 
burning sensation is main side effect of tacrolimus which can 
be overcome by incorporating into transfersomal carrier. 
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